NCI News Releases
The latest cancer news from the U.S. government's principal agency for cancer research.-
TCGA study of liver cancer reveals potential targets for therapy
Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist.
-
Study estimates number of U.S. women living with metastatic breast cancer
A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population and improvements in treatment.
-
Annual Report to the Nation: Cancer death rates continue to decline
According to the latest Annual Report to the Nation on the Status of Cancer, 1975-2014, overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups. But more work remains for some cancers.
NCI Fact Sheets
The latest NCI fact sheets on a wide array of cancer topics including risk factors, prevention, support, treatment, and more.-
Asbestos Exposure and Cancer Risk
A fact sheet about asbestos, asbestos-related diseases, and who to contact for more information.
-
Prostate-Specific Antigen (PSA) Test
A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test.
-
Hormone Therapy for Breast Cancer
A fact sheet that describes hormone therapy (including antiestrogens, LH-RH agonists, aromatase inhibitors, and SERMs) and its role in preventing and treating breast cancer. Includes information about possible side effects.
